Exactly one year ago, Jan and I heard about Mallory Smith’s imminent need for phage therapy. We decided that day to launch Phage Directory.

Our original mission was to help people access phage therapy. As a phage biologist, I knew there were thousands of phages out there (both in the environment, and in lab fridges and freezers). But I also knew there wasn’t typically a lot of communication between medical doctors and academic researchers. And Jan and I both knew that the number of people who’d heard of phages was small.

Jan was looking for a way to use his skills in product design and digital community-building on something that mattered. I was frustrated about how most of science is inaccessible to most people, and wanted to help change that fact.

Using technology to get lifesaving phages out of labs and into the hands of doctors made sense for both of us, so we launched Phage Directory.

Mallory Smith, the inspiration for this initiative, passed away two days after we started.

It would be an understatement to say that that makes celebrating our birthday this week bittersweet. Mallory continues to inspire us, and I think about her often. I sometimes re-read her beautifully written blog when I have a hard week.

But in the year since Mallory’s passing, we’ve watched phage therapy make the news over and over again. We’ve learned of new phage companies, new phage clinical trials, a new phage therapy center, and news of successful phage treatments. We’ve spoken with and visited phage researchers and phage companies around the world (they’re an amazingly hospitable bunch!). Our Twitter following has risen to almost 1200 people, and more than 120 people subscribed to Capsid & Tail within its first couple of weeks. When we send a Phage Alert, we get labs volunteering to help within hours.

It is our impression that interest in this forgotten industry truly seems to be ramping up. People seem to want to learn more about phages, and a surprising (and rising) number of phage researchers and medical doctors are willing to get involved in phage treatments. Health regulatory agencies in the USA (FDA) and in Europe (EMA) support these efforts.

We’re working to identify the current barriers to phage therapy so we can help mobilize the phage community to help break them down.

In addition to supporting phage therapy, we are also keenly looking to support those using phages in agriculture and other industries, as well as those doing fundamental phage research.

To sum up, we’re very proud of and grateful for our growing phage community. To all who participate in our phage hunts, email us, retweet us, read our posts, mention us to colleagues, and offer suggestions, THANK YOU! Here’s to the year ahead.

~ Jessica and Jan <>={